Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

sagi habasov

559 POSTS

Exclusive articles:

SKN | Driven Brands Earnings Preview: Can DRVN Reverse Its Underperformance Trend?

A Consumer Services Giant at a Crossroads Driven Brands Holdings Inc. (NASDAQ: DRVN) enters its April 15, 2026 earnings release with mounting pressure to demonstrate...

SKN | Obesity Biotech Kailera Therapeutics Sets Terms for $500 Million IPO

Kailera Therapeutics, a clinical-stage biotechnology company focused on obesity and metabolic disorders, has set terms for a $500 million IPO as it prepares for...

SKN | TTM Technologies Earnings Preview: Can TTMI Sustain Its Breakout Rally?

TTM Technologies, Inc. (NASDAQ: TTMI) has recently captured investor attention following a sharp upward move in its stock price, climbing to around $121 after...

SKN | Blackstone-Backed Encore Files for Estimated $500 Million IPO in Event Services Sector

Encore, an event services provider backed by Blackstone, has filed for an estimated $500 million IPO as it prepares to re-enter the public markets....

SKN | CarMax Earnings Preview: Can KMX Overcome Declining Sales and Stage a Comeback?

Earnings Day Approaches Amid Uncertainty CarMax, Inc. (NYSE: KMX) is set to report earnings on April 14, 2026, with investors closely watching for signs of...

Breaking

SKN | Geothermal Developer Fervo Energy Files for Estimated $250 Million IPO

Fervo Energy, a next-generation geothermal energy developer, has filed...

SKN | Mobia Medical Files for $100M IPO as Neurostimulation Therapy Targets $30B Stroke Market

FDA-Approved Device Positions Company in High-Value Neurorehabilitation Segment Mobia Medical...

SKN | Amatuhi Holdings Raises IPO Range as Investor Demand Lifts Expected Proceeds by 60%

Revised Pricing Signals Stronger Market Interest Ahead of Nasdaq...

SKN | Alamar Biosciences Prices Upsized IPO at $17, the High End of the Range

Alamar Biosciences has priced its upsized initial public offering...
spot_imgspot_img